Your browser doesn't support javascript.
loading
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
Mizukami, Takuro; Togashi, Yosuke; Naruki, Saeko; Banno, Eri; Terashima, Masato; de Velasco, Marco A; Sakai, Kazuko; Yoneshige, Azusa; Hayashi, Hidetoshi; Fujita, Yoshihiko; Tomida, Shuta; Nakajima, Takako Eguchi; Fujino, Takashi; Boku, Narikazu; Ito, Akihiko; Nakagawa, Kazuhiko; Nishio, Kazuto.
Afiliação
  • Mizukami T; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Togashi Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Naruki S; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Banno E; Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Terashima M; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • de Velasco MA; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Sakai K; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Yoneshige A; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Hayashi H; Department of Pathology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Fujita Y; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Tomida S; Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nakajima TE; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Fujino T; Department of Genome Biology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
  • Boku N; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Ito A; Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Nakagawa K; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Nishio K; Department of Pathology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
Mol Carcinog ; 56(1): 106-117, 2017 01.
Article em En | MEDLINE | ID: mdl-26916220
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Fator 9 de Crescimento de Fibroblastos / Receptores ErbB / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Fator 9 de Crescimento de Fibroblastos / Receptores ErbB / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão